{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:24:57Z","timestamp":1776338697963,"version":"3.51.2"},"reference-count":32,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["N41\/DBS\/000704"],"award-info":[{"award-number":["N41\/DBS\/000704"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Clostridioides difficile is still one of the most common causes of hospital-acquired infectious diarrhea (CDI), and the incidence of CDI is one of the indicators that allows conclusions to be derived on the correctness of antibiotic administration. The objective of this observational study was the analysis of post-discharge CDI incidence in patients undergoing hip or knee arthroplasty, in order to specify optimum conditions for the surgical procedures and outpatient postoperative care. One-year observational study. Public Polish hospitals. Retrospective records for 83,525 surgery patients having undergone hip or knee arthroplasty were extracted from the Polish National Health Fund databases. CDI and\/or antibiotic prescriptions in the 30 day post-surgery period were expressed per 1000 surgeries with antibiotic prescription on discharge or in ambulatory care, respectively. The CDI incidence rate was 34.4 per 10,000 patients, and 7.7 cases per 100,000 post-surgery patient-days. Patients who were prescribed at least one antibiotic were diagnosed with CDI more often than patients who had no antibiotic treatment (55.0\/1000 patients vs. 1.8\/1000 patients). In the multifactorial analysis, the following factors were significant: being at least 65 years of age, trauma as the cause of surgery, length of stay over 7 days, HAIs other than CDI and taking beta-lactams and\/or quinolones but not macrolides in the post-discharge period. Postoperative antibiotic prescription in patients undergoing joint replacement surgery is the main risk factor for CDI. These observations indicate the necessity of improvement of infection control programs as the key factor for CDI prevention.<\/jats:p>","DOI":"10.3390\/ijerph19063155","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T12:35:37Z","timestamp":1646742937000},"page":"3155","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Post-Discharge Clostridioides difficile Infection after Arthroplasties in Poland, Infection Prevention and Control as the Key Element of Prevention of C. difficile Infections"],"prefix":"10.3390","volume":"19","author":[{"given":"Estera","family":"Jachowicz","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Medical College, Jagiellonian University, 31-121 Krakow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6057-479X","authenticated-orcid":false,"given":"Agnieszka","family":"Pac","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Medical College, Jagiellonian University, 31-034 Krakow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"R\u00f3\u017ca\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Medical College, Jagiellonian University, 31-121 Krakow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Gryglewska","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Gerontology, Medical College, Jagiellonian University, 31-501 Krakow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-1639","authenticated-orcid":false,"given":"Jadwiga","family":"Wojkowska-Mach","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Medical College, Jagiellonian University, 31-121 Krakow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fmed.2018.00096","article-title":"Novel Antimicrobials for the Treatment of Clostridium difficile Infection","volume":"5","author":"Petrosillo","year":"2018","journal-title":"Front. Med."},{"key":"ref_2","first-page":"12","article-title":"Treatment of Clostridioides (Clostridium) difficile infection","volume":"5","author":"Oksi","year":"2020","journal-title":"Ann. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajic.2017.07.025","article-title":"Does surgical site infection after Caesarean section in Polish hospitals reflect high-quality patient care or poor postdischarge surveillance? Results from a 3-year multicenter study","volume":"46","author":"Jarynowski","year":"2018","journal-title":"Am. J. Infect. Control."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1089\/sur.2017.010","article-title":"Identifying the Infection Control Areas Requiring Modifications in Thoracic Surgery Units: Results of a Two-Year Surveillance of Surgical Site Infections in Hospitals in Southern Poland","volume":"18","author":"Dubiel","year":"2017","journal-title":"Surg. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jachowicz, E., Wa\u0142aszek, M., Sulimka, G., Maciejczak, A., Zie\u0144czuk, W., Ko\u0142odziej, D., Kara\u015b, J., Pobiega, M., and W\u00f3jkowska-Mach, J. (2020). Long-Term Antibiotic Prophylaxis in Urology and High Incidence of Clostridioides difficile Infections in Surgical Adult Patients. Microorganisms, 8.","DOI":"10.3390\/microorganisms8060810"},{"key":"ref_6","unstructured":"European Centre for Disease Prevention and Control (2018). Healthcare-associated infections: Clostridium difficile infections, Annual Epidemiological Report for 2016."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gajda, M., Pac, A., Gryglewska, B., Gajda, P., R\u00f3\u017ca\u0144ska, A., and W\u00f3jkowska-Mach, J. (2021). Patients Undergoing Hip or Knee Arthroplasty in Poland Based on National Data\u2014Challenge for Healthcare in Aging Society. Healthcare, 9.","DOI":"10.3390\/healthcare9080924"},{"key":"ref_8","unstructured":"(2021, October 01). 2012\/506\/EU: Commission Implementing Decision of 8 August 2012 Amending Decision 2002\/253\/EC Laying Down Case Definitions for Reporting Communicable Diseases to the Community Network under Decision No 2119\/98\/EC of the European Parliament and of the Council (Notified under Document C (2012) 5538) Text with EEA Relevance. Published 2012. Available online: https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2012:262:0001:0057:EN:PDF."},{"key":"ref_9","unstructured":"European Centre for Disease Prevention and Control (2017). European Surveillance of Clostridium Difficile Infection, Surveillance protocol version 2.3."},{"key":"ref_10","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2012). Guidelines for ATC Classification and DDD Assignment 2013."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Negrut, N., Bungau, S., Behl, T., Khan, S., Vesa, C., Bustea, C., Nistor-Cseppento, D., Rus, M., Pavel, F.-M., and Tit, D. (2020). Risk Factors Associated with Recurrent Clostridioides difficile Infection. Healthcare, 8.","DOI":"10.3390\/healthcare8030352"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Negrut, N., Nistor-Cseppento, D.C., Khan, S.A., Pantis, C., Maghiar, T.A., Maghiar, O., Aleya, S., Rus, M., Tit, D.M., and Aleya, L. (2020). Clostridium difficile Infection Epidemiology over a Period of 8 Years\u2014A Single Centre Study. Sustainability, 12.","DOI":"10.3390\/su12114439"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/501997","article-title":"Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly","volume":"23","author":"Simor","year":"2002","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1017\/ice.2018.106","article-title":"Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents","volume":"39","author":"Donskey","year":"2018","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/ice.2018.288","article-title":"Antibiotic prescribing upon discharge from the hospital to long-term care facilities: Implications for antimicrobial stewardship requirements in post-acute settings","volume":"40","author":"Weber","year":"2019","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13643-017-0554-z","article-title":"Effectiveness of person- and family-centered care transition interventions: A systematic review protocol","volume":"6","author":"Backman","year":"2017","journal-title":"Syst. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jmii.2014.04.011","article-title":"Clinical impact of Clostridium difficile colonization","volume":"48","author":"Hung","year":"2015","journal-title":"Microbiol. Immunol. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/cc11852","article-title":"Outcome of ICU patients with Clostridium difficile infection","volume":"16","author":"Zahar","year":"2012","journal-title":"Crit. Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MCC.0000000000000321","article-title":"Role of the microbiome, probiotics, and \u2018dysbiosis therapy\u2019 in critical illness","volume":"22","author":"Wischmeyer","year":"2016","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jamasurg.2019.0569","article-title":"Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events","volume":"154","author":"Strymish","year":"2019","journal-title":"JAMA Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Communityassociated Clostridium difficile infection and antibiotics: A meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Knecht, H., Neulinger, S.C., Heinsen, F.A., Knecht, C., Schilhabel, A., Schmitz-Streit, R.A., Zimmermann, A., Dos Santos, V.M., Ferrer, M., and Rosenstiel, P. (2014). Effects of \u03b2-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089417"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00264-019-04298-x","article-title":"Can surgical site infections be controlled through microbiological surveillance? A three-year laboratory-based surveillance at an orthopaedic unit, retrospective observatory study","volume":"43","author":"Bielecki","year":"2019","journal-title":"Int. Orthop."},{"key":"ref_24","unstructured":"European Centre for Disease Prevention and Control (2017). Healthcare-associated infections: Surgical site infections, Annual Epidemiological Report for 2015."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.arth.2017.08.004","article-title":"Incidence, Risk Factors, and Impact of Clostridium Difficile Colitis Following Primary Total Hip and Knee Arthroplasty","volume":"33","author":"Bovonratwet","year":"2018","journal-title":"J. Arthroplasty."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinternmed.2010.89","article-title":"Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection","volume":"170","author":"Howell","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: A meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00535-017-1371-9","article-title":"Meta-analysis: Proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth","volume":"53","author":"Su","year":"2018","journal-title":"J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/ice.2014.39","article-title":"Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: A systematic review and meta-analysis","volume":"36","author":"Stone","year":"2015","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13756-018-0428-8","article-title":"Antibiotic consumption and antimicrobial resistance in Poland; findings and implications","volume":"7","author":"Godman","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13756-021-01019-1","article-title":"Antibiotic consumption in long-term care facilities in Poland and other European countries in 2017","volume":"10","author":"Topolski","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"ref_32","unstructured":"EMA (2021, October 01). European Medicines Agency: Quinolone- and Fluoroquinolone-Containing Medicinal Products, Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/quinolone-fluoroquinolone-containing-medicinal-products."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/6\/3155\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:33:41Z","timestamp":1760135621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/6\/3155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijerph19063155"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19063155","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]}}}